Evidence map›Paper›PMID 32808608›Full record

ArticleChemical communications (Cambridge, England)2020

Chemically triggered crosslinking with bioorthogonal cyclopropenones.

R David Row, Sean S Nguyen, Andrew J Ferreira, Jennifer A Prescher

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Fluorogenic Coumarins Activated via Bioorthogonal Reactions.The Journal of organic chemistry · 2025
    Article
  3. Visible Light Triggerable CO Releasing Micelles.Journal of the American Chemical Society · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Recent Advances in Bioorthogonal Ligation and Bioconjugation.Topics in current chemistry (Cham) · 2023
    Review
  8. Platform for OrthogonalJournal of the American Chemical Society · 2022
    Article
  9. Fluorogenic Cyclopropenones for Multicomponent, Real-Time Imaging.Journal of the American Chemical Society · 2022
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R David RowDepartment of Chemistry, University of California, Irvine, California 92697, USA. jpresche@uci.edu.
Sean S NguyenDepartment of Chemistry, University of California, Irvine, California 92697, USA. jpresche@uci.edu.ORCID http://orcid.org/0000-0002-1801-5521
Andrew J FerreiraDepartment of Chemistry, University of California, Irvine, California 92697, USA. jpresche@uci.edu.
Jennifer A PrescherDepartment of Chemistry, University of California, Irvine, California 92697, USA. jpresche@uci.edu and Department of Molecular Biology & Biochemistry, University of California, Irvine, California 92697, USA and Department of Pharmaceutical Sciences, University of California, Irvine, California 92697, USA.ORCID http://orcid.org/0000-0002-9250-4702

Funding

Cyclopropenones to assemble, analyze, and activate biomoleculesR01GM126226 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI PRESCHER, JENNIFER · 2018 to 2021
$1.1M
NIGMS NIH HHS R01 GM126226
6 · The paper itself

Abstract

We report a proximity-driven crosslinking strategy featuring bioorthogonal cyclopropenones. These motifs react with phosphines to form electrophilic ketene-ylides. Such intermediates can be trapped by neighboring proteins to form covalent adducts. Successful crosslinking was achieved using a model split reporter, and the rate of crosslinking could be tuned using different phosphine triggers. We further demonstrated that the reaction can be performed in cell lysate. Based on these features, we anticipate that cyclopropenones will enable unique studies of protein-protein and other biomolecule interactions.

Indexed as

BacteriaBiocompatible MaterialsCross-Linking ReagentsCyclopropanesModels, MolecularMolecular StructurePhosphinesBiocompatible MaterialsCross-Linking ReagentsCyclopropanescyclopropenonePhosphines

Identifiers

PMID32808608
PMCPMC7501174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.